Shikiar Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,530
Closed -$780K 75
2023
Q3
$780K Sell
23,530
-113,025
-83% -$4M 0.27% 45
2023
Q2
$5.01M Sell
136,555
-56,425
-29% -$2.2M 1.62% 19
2023
Q1
$7.87M Buy
+192,980
New +$8.33M 2.8% 11
2018
Q1
Sell
-6,324
Closed -$217K 93
2017
Q4
$217K Hold
6,324
0.1% 78
2017
Q3
$214K Sell
6,324
-5,586
-47% -$180K 0.09% 99
2017
Q2
$380K Sell
11,910
-4,743
-28% -$150K 0.16% 74
2017
Q1
$541K Hold
16,653
0.24% 64
2016
Q4
$513K Sell
16,653
-527
-3% -$16.1K 0.22% 59
2016
Q3
$552K Buy
17,180
+6,324
+58% +$211K 0.24% 62
2016
Q2
$363K Hold
10,856
0.16% 84
2016
Q1
$305K Buy
+10,856
New +$310K 0.14% 91
2014
Q3
Sell
-123,265
Closed -$3.47M 114
2014
Q2
$3.47M Sell
123,265
-139,998
-53% -$3.99M 1.43% 28
2014
Q1
$8.02M Buy
263,263
+20,764
+9% +$619K 3.52% 2
2013
Q4
$7.05M Buy
242,499
+2,187
+0.9% +$63.6K 3.06% 6
2013
Q3
$6.55M Buy
240,312
+26,824
+13% +$730K 3.26% 6
2013
Q2
$5.67M Buy
+213,488
New +$5.9M 2.82% 9

Other funds holding PFE

Shikiar Asset Management's PFE Position: Q4 2023 in Review

Shikiar Asset Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 23,530 shares — an estimated $780K sold.

Shikiar Asset Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $8.02M in Q1 2014. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Shikiar Asset Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Shikiar Asset Management sold 23,530 Pfizer shares in Q4 2023, an estimated $780K.
  • Shikiar Asset Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • Shikiar Asset Management's Pfizer position peaked at $8.02M in Q1 2014.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Shikiar Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.